Candida Infection Testing Market Set to Grow at a Steady 6.1% CAGR Through 2030

The Business Research Company

Candida Infection Testing Market Overview

The Business Research Company's Candida Infection Testing Market Set to Grow at a Steady 6.1% CAGR Through 2030

LONDON, GREATER LONDON, UNITED KINGDOM, November 6, 2026 /EINPresswire.com/ -- "The candida infection testing market has been experiencing significant growth, fueled by various healthcare developments and increasing awareness. This sector plays a crucial role in diagnosing fungal infections and guiding effective treatment. Let’s explore the current market landscape, key growth drivers, regional outlook, and emerging trends shaping the future of candida infection testing.

Current Market Size and Projected Growth of the Candida Infection Testing Market
The candida infection testing market has witnessed strong expansion in recent years. It is projected to rise from $16.72 billion in 2025 to $17.8 billion in 2026, representing a compound annual growth rate (CAGR) of 6.4%. This historical growth has been driven by a rise in fungal infection cases, an increase in the number of immunocompromised patients, broader availability of hospital diagnostic services, the adoption of culture-based fungal testing techniques, and growing awareness about antifungal resistance. Looking ahead, the market is set to continue its upward trajectory, reaching $22.56 billion by 2030 with a CAGR of 6.1%. This future growth will be supported by demand for rapid fungal diagnostics, expanded use of molecular and microbiome testing, increased point-of-care fungal diagnostic options, higher investments in infectious disease diagnostics, and a stronger emphasis on personalized antifungal treatments. Notable trends include wider adoption of molecular detection methods for candida, increased use of rapid nucleic acid amplification test (NAAT)-based diagnostics, integration of microbiome assessments, growth in hospital-based fungal testing, and heightened focus on early identification of fungal infections.

Download a free sample of the candida infection testing market report:
https://thebusinessresearchcompany.com/sample_request?id=87089874&type=smp&name=Candida%20Infection%20Testing%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Understanding What Candida Infection Testing Entails
Candida infection testing comprises diagnostic methods aimed at detecting the presence of candida species, fungi responsible for infections in various parts of the body. These tests assess both the type and severity of the infection, providing critical information that helps healthcare providers tailor effective treatment plans.

The Rising Impact of Yeast Infections on Market Growth
One of the primary factors propelling the candida infection testing market is the growing incidence of yeast infections. These fungal infections, caused by an overgrowth of candida, typically affect areas such as the mouth, genitals, and skin, leading to symptoms like itching, redness, and discomfort. Yeast infections often result from disruptions in the body’s natural bacterial balance, weakened immune defenses, or hormonal fluctuations. Testing for candida in these cases is essential to accurately diagnose infection and guide appropriate medical intervention. For example, in May 2025, data from the UK Health Security Agency indicated a 4% rise in bloodstream yeast infections in England during 2024 compared to the previous year, with cases increasing from 2,170 to 2,247 and the incidence rate moving from 3.8 to 3.9 per 100,000 people. This upward trend in yeast infections is a significant factor driving demand for candida infection diagnostics.

View the full candida infection testing market report:
https://thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Regional Outlook: North America Leading Growth in Candida Infection Testing
In 2025, North America held the largest share of the global candida infection testing market. Key regions analyzed within this market include Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. While North America currently dominates, emerging markets in other regions are expected to contribute to future growth, driven by expanding healthcare infrastructure and increasing disease awareness.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X